Recon: China vaccinates 100K for COVID; EUA for Roche COVID-flu combo test

• Genentech scores sixth FDA approval in lung cancer with Gavreto (Pharmafile)
• US FDA Personnel Costs Drop: Is the Next Generation Taking Over? (Pink Sheet)
• Gottlieb: Staged Access To Coronavirus Vaccine Possible Through EUA (Pink Sheet)
• Why Saving The Economy Or Tackling The Pandemic Is A False Dilemma (Forbes)
• Here’s how Trump could bigfoot the FDA and get a vaccine out ahead of the science (WKTV/CNN)
• FDA Rejects Oleandrin, Extract Pushed By MyPillow CEO, As A Dietary Supplement (Forbes)

• Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme (Pharmafile) (Pink Sheet)
• President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros (Pharmafile)
• NICE no for Pierre Fabre's Braftovi (PharmaTimes)
• EU expands scope of Imbruvica to include untreated CLL patients (PharmaTimes)
• Same Price & Trial Data: Scotland OKs Spravato Funding After England Says No (Pink Sheet)
• WHO says India in talks to join 'COVAX' global vaccine scheme (Economic Times)
• Australia announces deal for 84 million COVID-19 vaccine doses (BioPharma Reporter)

• Senate to vote on scaled-down coronavirus relief package (The Hill)
• WHO warns against 'politically motivated' information in coronavirus response (The Hill)
• Pfizer CEO says people who don’t get vaccinated will become ‘weak link’ that allows coronavirus to spread (CNBC)
• Merck CEO Stresses Need For ‘Fair Return’ On COVID-19 Interventions (Scrip)
• Celltrion to begin mass producing antibody treatment before getting approval (Endpoints) (Reuters)
• Trump and Biden accuse each other of politicizing Covid-19 vaccine (Financial Times)
• Sinovac’s COVID-19 vaccine appears safe in older adults (PMLive)
• Progress on BioNTech and Pfizer’s COVID-19 vaccine candidate BNT162b2 (PharmaLetter)
• World must be better prepared for next pandemic, WHO says (CNBC)
• India surpasses Brazil, second behind U.S., in total coronavirus cases (NBC) (NPR)
• How Can You Tell If A COVID-19 Vaccine Is Working? (NPR)
• Inovio partners with Thermo Fisher to bolster COVID-19 vaccine supply (Reuters)

• Finance Watch: One Small Pain Drug Maker And Three Biotech SPACs Launch IPOs (Scrip)
• Takeda to sell another non-core portfolio for $260 million to Cheplapharm (Pharmafile)
• Extension study reveals Dupixent's benefit can last up to three years in moderate-to-severe asthma (Pharmafile)
• Gilead’s Kite submits FDA approval application for CAR-T in slow-growing lymphomas (MedCity News)
• Sanofi's later-stage trials hardest hit by COVID-19: report (Fierce Biotech)
• Merck chronic cough drug shows mixed results in late-stage clinical trials, raising questions about its future (STAT) (Endpoints)
• After carefully building up expectations, a small-cap biotech’s big plans come crashing down in PhIII catastrophe (Endpoints)
• Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio (Endpoints)

• Daily Coronavirus Testing at Home? Many Experts Are Skeptical (NYT)
• ‘An unchartered situation for all of us’: From shipping containers to security concerns, a Covid-19 vaccine supply chain takes shape (STAT)
• Roche COVID-19, flu combo test gets FDA emergency authorization (MedTech Dive)
• FDA flags 428 spinal cord stimulator patient deaths, urges more tests before implant (MedTech Dive)
• Boston Scientific, Stryker win CMS new tech add-on pay, BD left out (MedTech Dive)
• Roche BK Virus Test Garners FDA Clearance (GenomeWeb)

• Major COVID-19 Rule Leads Busy Week (American Action Forum)
• HHS Unit Probes Funding For Moderna's Patented Vaccines (Law360) (STAT)
• Court Halts Boehringer’s COPD Inhaler Comparative Claims Vs. GSK Products (Pink Sheet)
• Bold Action Needed to Save Medicare, Says MedPAC Commissioner (MedPage Today)
• Evidence of 510(k) Clearance Is Relevant and Admissible, Says E.D. Pa. IVC Filter Judge (Drug & Device Law)
• Why did the US justice department let Purdue off the hook for the opioid crisis? (Guardian)